Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 922,551 | 524,353 | 199,752 | 801,695 | 684,778 |
| Depreciation Amortization | 1,317,181 | 873,648 | 415,461 | 1,885,296 | 1,391,276 |
| Income taxes - deferred | -35,717 | -60,289 | -32,118 | -78,638 | -131,034 |
| Accounts receivable | -196,373 | -124,433 | -308,824 | -79,510 | -109,031 |
| Accounts payable and accrued liabilities | 36,124 | -6,659 | 53,014 | -49,993 | -26,261 |
| Other Working Capital | -17,143 | -117,108 | -405,623 | 480,791 | 249,713 |
| Other Operating Activity | -63,674 | -24,974 | 249,872 | -377,596 | -350,177 |
| Operating Cash Flow | $1,962,949 | $1,064,538 | $171,535 | $2,582,046 | $1,709,264 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -561,908 | -327,845 | -149,908 | -741,514 | -497,200 |
| Net Acquisitions | 169,385 | 5,118 | 13,361 | 656,492 | 531,726 |
| Purchase Of Investment | -29,742 | -12,945 | -12,189 | -88,192 | -71,022 |
| Sale Of Investment | 66,568 | 51,537 | 34,704 | 81,303 | 74,163 |
| Investing Cash Flow | $-355,696 | $-284,135 | $-114,032 | $-91,913 | $37,667 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 186,260 | 107,004 | 97,041 | 91,775 | 200,443 |
| Debt Issued | 1,311,264 | 1,264,843 | 14,850 | 66,563 | 44,381 |
| Debt Repayment | -970,473 | -359,751 | -15,158 | -902,971 | -274,595 |
| Common Stock Repurchased | -176,643 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,084,528 | -613,300 | -67,855 | -717,273 | -580,394 |
| Other Financing Activity | -662,502 | -466,415 | -175,092 | -1,318,334 | -1,153,719 |
| Financing Cash Flow | $-1,396,623 | $-67,618 | $-146,213 | $-2,780,240 | $-1,763,885 |
| Exchange Rate Effect | -127,762 | -105,670 | -23,634 | 28,349 | -27,045 |
| Beginning Cash Position | 1,385,530 | 1,345,584 | 1,248,743 | 1,544,400 | 1,569,377 |
| End Cash Position | 1,468,398 | 1,952,699 | 1,136,399 | 1,282,643 | 1,525,378 |
| Net Cash Flow | $82,868 | $607,115 | $-112,344 | $-261,757 | $-43,998 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,962,949 | 1,064,538 | 171,535 | 2,582,046 | 1,709,264 |
| Capital Expenditure | -575,516 | -340,722 | -153,558 | -756,775 | -504,351 |
| Free Cash Flow | 1,387,433 | 723,816 | 17,977 | 1,825,271 | 1,204,913 |